Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis

BMJ Case Reports

Volumn , Issue , 2011, Pages

  Ahmed, Zahra ^a   Powell, Robert ^b   Llewelyn, Gareth ^b   Anstey, Alex ^b  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; EFALIZUMAB; IMMUNOGLOBULIN; PREDNISOLONE;

ADULT; AREFLEXIA; ARTICLE; CASE REPORT; CONVALESCENCE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HYPERESTHESIA; LIMB WEAKNESS; NERVE CONDUCTION; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PSORIASIS VULGARIS; WALKING DIFFICULTY;

EID: 84855508022     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.08.2011.4674     Document Type: Article

References (5)

1. Lozeron P, Denier C, Lacroix C, et al. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol 2009;66:490-7.
2. Magnano MD, Robinson WH, Genovese MC. Demyelination and inhibition of tumor necrosis factor (TNF). Clin Exp Rheumatol 2004;22(5 Suppl 35):S134-40. (Pubitemid 39328366)
3. Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 2001;44:1977-83. (Pubitemid 33644038)
4. Alshekhlee A, Basiri K, Miles JD, et al. Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists. Muscle Nerve 2010;41:723-7.
5. Das A, Kalita J, Misra UK. Recurrent Guillain Barre' syndrome. Electromyogr Clin Neurophysiol 2004;44:95-102. (Pubitemid 38332079)